Significados de new gadolinium en inglés

The key secondary endpoint was time to relapse or new gadolinium-enhancing or T2 lesions on MRI, whichever occurred first.

Conclusion: A new gadolinium-loaded nanoparticle with high relaxativity was synthesized successfully, and might serve as a carrier for magnetic resonance molecular imaging.

The primary endpoint was total number of new gadolinium enhancing (GdE) lesions on brain MRI scans at weeks 12, 16, 20, and 24.

A trend toward improvement in new Gadolinium-enhancing lesions on MRI was observed, but this difference was not statistically significant.